We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+9.23%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$4.22B
AUM Growth
-$1.2B
Cap. Flow
-$1.32B
Cap. Flow %
-31.23%
Top 10 Hldgs %
40.53%
Holding
893
New
143
Increased
129
Reduced
82
Closed
273
Avg Time Held Equity + Options
3.6 quarters
Top 10 Avg Time Held Equity + Options
0.7 quarters
Top 20 Avg Time Held Equity + Options
0.8 quarters
Avg Time Held Equity only
3.7 quarters
Top 10 Avg Time Held Equity only
0.7 quarters
Top 20 Avg Time Held Equity only
0.8 quarters

Top Buys

Rank Stock Value
1
OSH
Oak Street Health, Inc.
OSH
+$211M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$189M
3
UNVR
Univar Solutions Inc.
UNVR
+$175M
4
MAXR
Maxar Technologies Inc. Common Stock
MAXR
+$143M
5
AQUA
Evoqua Water Technologies Corp. Common Stock
AQUA
+$137M

Top Sells

Rank Stock Value
1
STOR
STORE Capital Corporation
STOR
+$414M
2
LHCG
LHC Group LLC
LHCG
+$211M
3
ATVI
Activision Blizzard
ATVI
+$196M
4
SGFY
Signify Health, Inc.
SGFY
+$161M
5
ONEM
1Life Healthcare
ONEM
+$141M

Sector Composition

Rank Sector Weight
1 Financials 22.21%
2 Healthcare 21.3%
3 Technology 18.64%
4 Miscellaneous 15.12%
5 Industrials 5.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
ORIA
251
DELISTED
Orion Biotech Opportunities Corp. Class A Ordinary Share
ORIA
$2.41M 0.06%
235,390
– –
2021 Q3
6 quarters
PEGR icon
252
DELISTED
Project Energy Reimagined Acquisition Corp. Class A Ordinary Share
PEGR
$2.41M 0.06%
236,311
– –
2022 Q1
4 quarters
KNSW
253
DELISTED
KnightSwan Acquisition Corporation
KNSW
$2.41M 0.06%
231,686
– –
2022 Q1
4 quarters
PNST icon
254
DELISTED
Pinstripes Holdings, Inc.
PNST
$2.41M 0.06%
231,686
– –
2022 Q1
4 quarters
KVSC
255
DELISTED
Khosla Ventures Acquisition Co. III Class A Common Stock
KVSC
$2.41M 0.06%
237,220
– –
2021 Q1
8 quarters
TGVC
256
DELISTED
TG Venture Acquisition Corp. Class A Common Stock
TGVC
$2.4M 0.06%
231,686
– –
2021 Q4
5 quarters
CSLM icon
257
DELISTED
CSLM Acquisition Corp. Class A Ordinary Share
CSLM
$2.4M 0.06%
231,686
– –
2022 Q1
4 quarters
BIIB icon
258
Biogen
BIIB
$33.3B
$2.39M 0.06%
8,610
+1,545
+22% +$427K
2022 Q3
2 quarters
ASBP icon
259
Aspire-Lakewood Holdings, Inc. Common Stock
ASBP
$11.6M
$2.38M 0.06%
190
– –
2022 Q2
3 quarters
RARE icon
260
Ultragenyx Pharmaceutical
RARE
$1.53B
$2.38M 0.06%
59,276
+9,727
+20% +$417K
2022 Q4
1 quarter
EONR icon
261
EON Resources
EONR
$26.6M
$2.38M 0.06%
227,558
– –
2022 Q2
3 quarters
FLD icon
262
Fold Holdings
FLD
$32.4M
$2.37M 0.06%
231,686
– –
2022 Q1
4 quarters
FGMC
263
DELISTED
FG Merger Corp. Common Stock
FGMC
$2.37M 0.06%
227,558
– –
2022 Q2
3 quarters
IMCR icon
264
Immunocore
IMCR
$1.51B
$2.37M 0.06%
47,865
+10,613
+28% +$597K
2022 Q1
4 quarters
IGTA icon
265
DELISTED
Inception Growth Acquisition Limited Common Stock
IGTA
$2.36M 0.06%
231,686
– –
2022 Q1
4 quarters
ZTO icon
266
ZTO Express
ZTO
$15.1B
$2.36M 0.06%
82,358
+54,075
+191% +$1.48M
2021 Q2
7 quarters
PSPC
267
DELISTED
Post Holdings Partnering Corporation
PSPC
$2.34M 0.06%
231,686
– –
2022 Q1
4 quarters
ALCE
268
DELISTED
Alternus Clean Energy Inc
ALCE
$2.34M 0.06%
9,102
– –
2022 Q2
3 quarters
KNSA icon
269
Kiniksa Pharmaceuticals
KNSA
$6.22B
$2.33M 0.06%
216,210
+59,248
+38% +$781K
2022 Q3
2 quarters
MTAL icon
270
DELISTED
Metals Acquisition
MTAL
$2.33M 0.06%
227,558
– –
2021 Q3
6 quarters
KPTI icon
271
Karyopharm Therapeutics
KPTI
$13.7M
$2.31M 0.05%
39,587
+11,966
+43% +$591K
2022 Q1
4 quarters
BSX icon
272
Boston Scientific
BSX
$61.9B
$2.3M 0.05%
46,008
-9,809
-18% -$462K
2022 Q1
4 quarters
INSP icon
273
Inspire Medical Systems
INSP
$1.99B
$2.29M 0.05%
9,765
+465
+5% +$118K
2022 Q3
2 quarters
XENE icon
274
Xenon Pharmaceuticals
XENE
$3.53B
$2.27M 0.05%
63,391
-981
-2% -$36.2K
2022 Q1
4 quarters
CMG icon
275
Chipotle Mexican Grill
CMG
$40B
$2.24M 0.05%
+65,600
New +$2.06M
2023 Q1
0 quarters
9 10
11
12 13

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q1 2023 Portfolio in Review

As of Q1 2023, UBS O'Connor held 893 positions worth $4.22B, down 22% from $5.42B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

UBS O'Connor withdrew a net $1.32B in Q1 2023, closing 273 positions and reducing 82 holdings. Its most notable exit was STORE Capital Corporation, an estimated $414M position sold in full.

By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 26% a quarter earlier, followed by Healthcare and Technology.

Against the trend, UBS O'Connor opened a new position in Oak Street Health, Inc. worth $25.3M.

  • UBS O'Connor's largest Q1 2023 buy was Oak Street Health, Inc.: 6,537,297 shares worth $25.3M.
  • UBS O'Connor added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, an estimated $189M increase.
  • UBS O'Connor's biggest Q1 2023 reduction was Activision Blizzard, cutting an estimated $196M.
  • UBS O'Connor fully exited STORE Capital Corporation in Q1 2023, selling an estimated $414M.
  • UBS O'Connor's ten largest holdings make up 41% of its $4.22B portfolio in Q1 2023.
  • UBS O'Connor opened 143 new positions and closed 273 in Q1 2023.
  • UBS O'Connor's portfolio value fell 22% quarter-over-quarter to $4.22B.

Based on UBS O'Connor's 13F filing for Q1 2023, filed 15 May 2023.